[go: up one dir, main page]

MD2722B2 - Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei - Google Patents

Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei Download PDF

Info

Publication number
MD2722B2
MD2722B2 MDA20020265A MD20020265A MD2722B2 MD 2722 B2 MD2722 B2 MD 2722B2 MD A20020265 A MDA20020265 A MD A20020265A MD 20020265 A MD20020265 A MD 20020265A MD 2722 B2 MD2722 B2 MD 2722B2
Authority
MD
Moldova
Prior art keywords
vitamin
pharmaceutical composition
magnesium
osteoporosis
prophylaxis
Prior art date
Application number
MDA20020265A
Other languages
English (en)
Romanian (ro)
Russian (ru)
Other versions
MD20020265A (en
Inventor
Любослав Разус
Юрай ВЕНДЛ
Иван Варга
Пётр ШИМЕК
Original Assignee
Словакофарма А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Словакофарма А.С. filed Critical Словакофарма А.С.
Publication of MD20020265A publication Critical patent/MD20020265A/xx
Publication of MD2722B2 publication Critical patent/MD2722B2/ro

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MDA20020265A 2000-04-06 2001-03-15 Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei MD2722B2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SK498-2000A SK284948B6 (sk) 2000-04-06 2000-04-06 Liečivý prípravok s obsahom vápnika alebo zmesi vápnika a vitamínu D, alebo zmesi vápnika a horčíka v novej liekovej forme
PCT/SK2001/000004 WO2001076610A1 (fr) 2000-04-06 2001-03-15 Composition pharmaceutique de formule nouvelle contenant du calcium, ou du calcium ou de la vitamine d, ou du calcium et du magnesium

Publications (2)

Publication Number Publication Date
MD20020265A MD20020265A (en) 2003-05-31
MD2722B2 true MD2722B2 (ro) 2005-03-31

Family

ID=20435843

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20020265A MD2722B2 (ro) 2000-04-06 2001-03-15 Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei

Country Status (10)

Country Link
EP (1) EP1274447A1 (fr)
AU (1) AU2001239668A1 (fr)
BG (1) BG107227A (fr)
CZ (1) CZ303069B6 (fr)
EE (1) EE200200584A (fr)
MD (1) MD2722B2 (fr)
PL (1) PL357777A1 (fr)
RU (1) RU2002130196A (fr)
SK (1) SK284948B6 (fr)
WO (1) WO2001076610A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067150B2 (en) 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
JP5154924B2 (ja) 2004-05-11 2013-02-27 エガレット エイ/エス ジェランガムを含む膨張可能な投与形態
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
DK2315580T3 (da) * 2009-03-26 2012-04-10 Pulmatrix Inc Farmaceutiske formuleringer og fremgangsmåder til behandling af luftvejsinfektioner
PT2410981T (pt) 2009-03-26 2017-05-25 Pulmatrix Inc Formulações em pó seco e métodos para tratar doenças pulmonares
US20130164338A1 (en) 2010-08-30 2013-06-27 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
CA3086367A1 (fr) 2010-09-29 2012-04-05 Pulmatrix Operating Company, Inc. Poudres seches a cations metalliques monovalents pour inhalation
CN104487075A (zh) 2012-02-29 2015-04-01 普马特里克斯公司 可吸入干粉剂
AU2014248455B2 (en) 2013-04-01 2018-12-06 Pulmatrix Operating Company, Inc. Tiotropium dry powders
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
RU2726438C2 (ru) * 2018-11-14 2020-07-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) Способ получения сухой высокобелковой молочной смеси для профилактики остеопении у детей и подростков с целиакией
CN109453126A (zh) * 2018-12-07 2019-03-12 浙江核力欣健药业有限公司 一种碳酸钙d3咀嚼片的组合物及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587399A (en) * 1992-12-23 1996-12-24 Abbott Laboratories Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
WO1999047122A1 (fr) * 1998-03-16 1999-09-23 Smtm Group, Llc Supplement en calcium a croquer et son procede de fabrication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
CA1297035C (fr) * 1987-12-29 1992-03-10 Warner-Lambert Canada Inc. Tablette a macher, non granuleuse, de citrate de calcium
US5296476A (en) * 1989-09-08 1994-03-22 Henderson Esther G Skin care compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587399A (en) * 1992-12-23 1996-12-24 Abbott Laboratories Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
WO1999047122A1 (fr) * 1998-03-16 1999-09-23 Smtm Group, Llc Supplement en calcium a croquer et son procede de fabrication

Also Published As

Publication number Publication date
CZ303069B6 (cs) 2012-03-21
EP1274447A1 (fr) 2003-01-15
WO2001076610A1 (fr) 2001-10-18
SK284948B6 (sk) 2006-03-02
SK4982000A3 (en) 2001-10-08
BG107227A (en) 2003-05-30
MD20020265A (en) 2003-05-31
EE200200584A (et) 2004-04-15
AU2001239668A1 (en) 2001-10-23
RU2002130196A (ru) 2004-03-27
PL357777A1 (en) 2004-07-26

Similar Documents

Publication Publication Date Title
ES2202601T5 (es) Mejora del sabor de sustancias activas de medicamentos
MD2722B2 (ro) Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei
WO2001041770A3 (fr) Compositions d'eplerenone nanoparticulaire
MY118371A (en) Tetrahydrolipstatin containing compositions
WO2002045684A3 (fr) Composition pharmaceutique a dispersion rapide
US3590117A (en) Long-lasting troche containing guar gum
IE48879B1 (en) An analgesic effervescent powder and process for its preparation
US3632778A (en) Tablets containing l-dopa
ZA200301007B (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations.
US5922351A (en) Lubricants for use in tabletting
US6403083B1 (en) Interleukin-12 inducer and medical composition
JP6580414B2 (ja) 生薬末含有錠剤
WO2008079343A3 (fr) Comprimés à désintégration par voie orale contenant une dose élevée de principes actifs: composition utilisée et méthodes de fabrication
WO2003061557A3 (fr) Compositions pharmaceutiques a base de levothyroxine, methodes de fabrication et d'administration associees
KR20010052819A (ko) 사이클로포스파미드 제피 정제
US2967131A (en) Therapeutic composition
EP0305968A3 (fr) Compositions contre des maladies protozoiques
JP6641626B2 (ja) 制酸用医薬組成物
JP6771274B2 (ja) 内服用組成物
JP4899304B2 (ja) 塩酸アンブロキソール含有内服用固形製剤
EP0272393A3 (fr) Mélange pharmaceutique
NZ315632A (en) Process for preparing solid dosage forms of very low-dose drugs comprising admixing 1-3% by weight of carrier particles with a solution of drug in water
TW561057B (en) Orally rapidly disintegrable tablet capabling of reducing the bitterness
UA79567C2 (en) Orodispersible pharmaceutical composition of antithrombolic compound
GB2336999A (en) High-dosage triclosan compositions